1887
Research article Open Access
Like 0

Abstract

Background and aim

Management of health issues presented by newly arrived migrants is often limited to communicable diseases even though other health issues may be more prevalent. We report the results of infectious disease screening proposed to 462 recently-arrived asylum seekers over 14 years of age in Verona province between April 2014 and June 2015. Screening for latent tuberculosis (TB) was performed via tuberculin skin test (TST) and/or QuantiFERON-TB Gold in-tube assay and/or chest X-ray. An ELISA was used to screen for syphilis. Stool microscopy was used to screen for helminthic infections, and serology was also used for strongyloidiasis and schistosomiasis. Screening for the latter also included urine filtration and microscopy. Most individuals came from sub-Saharan Africa (77.5%), with others coming from Asia (21.0%) and North Africa (1.5%). The prevalence of viral diseases/markers of human immunodeficiency virus (HIV) infection was 1.3%, HCV infection was 0.85% and hepatitis B virus surface antigen was 11.6%. Serological tests for syphilis were positive in 3.7% of individuals. Of 125 individuals screened for TB via the TST, 44.8% were positive and of 118 screened via the assay, 44.0% were positive. Of 458 individuals tested for strongyloidiasis, 91 (19.9%) were positive, and 76 of 358 (21.2%) individuals from sub-Saharan Africa were positive for schistosomiasis. The screening of viral diseases is questionable because of low prevalence and/or long-term, expensive treatments. For opposing reasons, helminthic infections are probably worth to be targeted by screening strategies in asylum seekers of selected countries of origin.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.16.17-00527
2018-04-19
2024-10-13
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2018.23.16.17-00527
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/23/16/eurosurv-23-16-2.html?itemId=/content/10.2807/1560-7917.ES.2018.23.16.17-00527&mimeType=html&fmt=ahah

References

  1. International Organization for Migration (IOM). IOM Releases Global Migration Trends 2015 Factsheet. INSERT Berlin; IOM; 19 Apr 2016. Available from: https://www.iom.int/news/iom-releases-global-migration-trends-2015-factsheet
  2. Italian Senate. Immigrazione. Elementi introduttivi. [Immigration. Introductory elements]. Rome: Italian Senate. [Accessed 17 Apr 2018]. Italian. Available from: http://www.senato.it/japp/bgt/showdoc/17/DOSSIER/1000651/index.html?part=dossier_dossier1&parse=si
  3. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381(9873):1235-45.  https://doi.org/10.1016/S0140-6736(12)62086-8  PMID: 23541058 
  4. Napoli C, Dente MG, Kärki T, Riccardo F, Rossi P, Declich S, et al. Network for the Control of Cross-Border Health Threats in the Mediterranean Basin and Black Sea. Screening for Infectious Diseases among Newly Arrived Migrants: Experiences and Practices in Non-EU Countries of the Mediterranean Basin and Black Sea. Int J Environ Res Public Health. 2015;12(12):15550-8.  https://doi.org/10.3390/ijerph121215002  PMID: 26670237 
  5. Schepisi MS, Gualano G, Piselli P, Mazza M, D’Angelo D, Fasciani F, et al. Active Tuberculosis Case Finding Interventions Among Immigrants, Refugees and Asylum Seekers in Italy. Infect Dis Rep. 2016;8(2):6594. PMID: 27403270 
  6. Zammarchi L, Casadei G, Strohmeyer M, Bartalesi F, Liendo C, Matteelli A, et al. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries. BMC Health Serv Res. 2015;15(1):412.  https://doi.org/10.1186/s12913-015-1045-3  PMID: 26399233 
  7. Crepet A, Repetto E, Al Rousan A, Sané Schepisi M, Girardi E, Prestileo T, et al. Lessons learnt from TB screening in closed immigration centres in Italy. Int Health. 2016;8(5):324-9.  https://doi.org/10.1093/inthealth/ihw025  PMID: 27208040 
  8. Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Caprio N, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. Euro Surveill. 2015;20(35):30009.  https://doi.org/10.2807/1560-7917.ES.2015.20.35.30009  PMID: 26530499 
  9. El-Hamad I, Pezzoli MC, Chiari E, Scarcella C, Vassallo F, Puoti M, et al. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med. 2015;22(2):78-86.  https://doi.org/10.1111/jtm.12176  PMID: 25424439 
  10. Lifson AR, Thai D, O’Fallon A, Mills WA, Hang K. Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota. Public Health Rep. 2002;117(1):69-77.  https://doi.org/10.1016/S0033-3549(04)50110-3  PMID: 12297684 
  11. Persson A, Rombo L. Intestinal parasites in refugees and asylum seekers entering the Stockholm area, 1987-88: evaluation of routine stool screening. Scand J Infect Dis. 1994;26(2):199-207.  https://doi.org/10.3109/00365549409011784  PMID: 8036476 
  12. Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis. 2007;45(10):1310-5.  https://doi.org/10.1086/522529  PMID: 17968826 
  13. Bocanegra C, Salvador F, Sulleiro E, Sánchez-Montalvá A, Pahissa A, Molina I. Screening for imported diseases in an immigrant population: experience from a teaching hospital in Barcelona, Spain. Am J Trop Med Hyg. 2014;91(6):1277-81.  https://doi.org/10.4269/ajtmh.14-0206  PMID: 25331805 
  14. Caruana SR, Kelly HA, Ngeow JY, Ryan NJ, Bennett CM, Chea L, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med. 2006;13(4):233-9.  https://doi.org/10.1111/j.1708-8305.2006.00045.x  PMID: 16884406 
  15. Centers for Disease Control and Prevention (CDC). Domestic Intestinal Parasite Guidelines. Presumptive Treatment and Screening for Strongyloidiasis, Schistosomiasis and Infections Caused by Soil-Transmitted Helminths for Refugees. Atlanta: CDC; 6 Nov 2013. [Accessed 17 Apr 2018]. Available from: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/intestinal-parasites-domestic.html https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas/intestinal-parasites-overseas.html
  16. Geltman PL, Cochran J, Hedgecock C. Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas pre-departure treatment program. Am J Trop Med Hyg. 2003;69(6):657-62. PMID: 14740885 
  17. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med. 1999;340(10):773-9.  https://doi.org/10.1056/NEJM199903113401006  PMID: 10072413 
  18. Martelli G, Di Girolamo C, Zammarchi L, Angheben A, Morandi M, Tais S, et al. Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. Clin Microbiol Infect. 2017;23(5):335.e1-5.  https://doi.org/10.1016/j.cmi.2017.02.024  PMID: 28259548 
  19. Centers for Disease Control and Prevention (CDC). Epi Info. Atlanta: CDC. [Accessed 28 Jul 2017]. Available from: https://www.cdc.gov/epiinfo/index.html
  20. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. [Accessed 28 Jul 2017]. Available from: https://www.R-project.org
  21. Pavli A, Maltezou H. Health problems of newly arrived migrants and refugees in Europe. J Travel Med. 2017;24(4).  https://doi.org/10.1093/jtm/tax016  PMID: 28426115 
  22. Sigvardsdotter E, Vaez M, Rydholm Hedman AM, Saboonchi F. Prevalence of torture and other warrelated traumatic events in forced migrants: A systematic review. Torture. 2016;26(2):41-73. PMID: 27858780 
  23. Hermans MPJ, Kooistra J, Cannegieter SC, Rosendaal FR, Mook-Kanamori DO, Nemeth B. Healthcare and disease burden among refugees in long-stay refugee camps at Lesbos, Greece. Eur J Epidemiol. 2017;32(9):851-4.  https://doi.org/10.1007/s10654-017-0269-4  PMID: 28597126 
  24. Monge-Maillo B, López-Vélez R, Norman FF, Ferrere-González F, Martínez-Pérez Á, Pérez-Molina JA. Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge. Am J Trop Med Hyg. 2015;92(4):848-56.  https://doi.org/10.4269/ajtmh.14-0520  PMID: 25646257 
  25. Maaßen W, Wiemer D, Frey C, Kreuzberg C, Tannich E, Hinz R, et al. Microbiological screenings for infection control in unaccompanied minor refugees: the German Armed Forces Medical Service’s experience. Mil Med Res. 2017;4(13).  https://doi.org/10.1186/s40779-017-0123-8  PMID: 28451440 
  26. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect. 2004;132(6):1055-63.  https://doi.org/10.1017/S0950268804003000  PMID: 15635962 
  27. Istituto Nazionale per la promozione della salute delle popolazioni Migranti e per il contrasto delle malattie della Povertà (INMP)/Istituto Superiore di Sanità (ISS)/Società Italiana di Medicina delle Migrazioni (SIMM). I controlli alla frontiera. La frontiera dei controlli. [Controls at the border. The border of control]. Rome: Ministry of Health; 2017. [Accessed 17 Apr 2018]. Italian. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2624_allegato.pdf
/content/10.2807/1560-7917.ES.2018.23.16.17-00527
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error